Intensive care medicine Intensive Care Medicine, 47, 8, pp. 867-886 Investigators, REMAP-CAP & Dark, P 2021, ' Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. ', Intensive care medicine, vol. 47, no. 8, pp. 867-886 . https://doi.org/10.1007/s00134-021-06448-5 2021, ' Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19 : REMAP-CAP randomized controlled trial ', Intensive Care Medicine, vol. 47, no. 8, pp. 867-886 . https://doi.org/10.1007/s00134-021-06448-5 Intensive care medicine, vol 47, iss 8 Arabi, Y M 2021, ' Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19 : REMAP-CAP randomized controlled trial ', Intensive Care Medicine, vol. 47, no. 8, pp. 867-886 . https://doi.org/10.1007/s00134-021-06448-5 Intensive Care Medicine, 47, 867-886 Intensive care medicine, 47(8), 867-886. Springer Verlag INTENSIVE CARE MEDICINE Intensive Care Medicine
Annals of the American Thoracic Society Annals of the American Thoracic Society, vol 17, iss 7 Proceedings of the American Thoracic Society Annals of the American Thoracic Society, 17(7), 879-891. American Thoracic Society